Treating JOAG: Why Surgery is Often First-Line
At a Glance
For Juvenile Open-Angle Glaucoma (JOAG), doctors often recommend surgeries like GATT as a first-line treatment instead of relying solely on eye drops. Early surgery safely opens the eye's natural drainage system to achieve a target eye pressure and prevent permanent vision loss.
In many cases of Juvenile Open-Angle Glaucoma (JOAG), eye drops are not enough to protect vision over the long term. Because JOAG can be very aggressive, doctors often use a “surgery-first” or “early-surgery” approach [1][2]. The goal is simple: to reach a Target IOP (intraocular pressure) that is low enough to stop the optic nerve from being damaged [3].
The Treatment Decision Tree
Managing JOAG is a balance between medications and surgical options. While eye drops are often the first step, relying on them for too long when they aren’t working can be counterproductive.
- Medications (Eye Drops): Medications work either by decreasing the amount of fluid the eye produces or by helping increase the drainage out of the eye. While used to lower pressure, their effectiveness often fades in JOAG. Using more than two or three different types of drops can cause “medication toxicity,” as the preservatives in the drops frequently cause tissue scarring that makes future surgeries less successful [2][4].
- Angle-Based Surgeries (First-Line Surgery): These procedures, like GATT (Gonioscopy-Assisted Transluminal Trabeculotomy) or goniotomy, aim to open the eye’s natural drainage system [5][6].
- Filtering Surgeries (Fallback Options): If angle surgeries fail, procedures like trabeculectomy or Glaucoma Drainage Devices (GDD) are used to create a completely new drain for the eye [7][8].
Why GATT is a Game-Changer for JOAG
GATT has become a preferred surgical option for JOAG, especially for patients with the MYOC gene mutation [9][10].
- Targeted Treatment: As discussed in the genetics section, JOAG is often caused by a blockage in the trabecular meshwork. GATT uses a tiny catheter to “unzip” this meshwork 360 degrees, clearing the blockage and allowing fluid to flow freely again [11][9].
- Fewer Complications: Because GATT works with the eye’s natural anatomy rather than creating an external “bleb” (a blister-like drain), it has a lower risk of long-term infection compared to older surgeries [11][12].
What to Expect on Surgery Day
On the day of a surgery like GATT, the patient is typically under general anesthesia or deep sedation. The procedure itself is usually outpatient, meaning you go home the same day. The immediate recovery week usually involves resting at home with a protective shield over the eye and using specific anti-inflammatory eye drops. The most common side effect during this early recovery is a hyphema—a temporary amount of blood in the front of the eye that usually clears up on its own within a week [11][12].
When More Advanced Surgery is Needed
If angle-based surgeries don’t lower the pressure enough, the surgical team may move to more “traditional” glaucoma surgeries:
- Trabeculectomy with Mitomycin-C: The surgeon creates a tiny flap in the white of the eye (sclera) to let fluid drain out into a “bleb” under the eyelid. Mitomycin-C is a medication used during surgery to prevent scarring [8][13]. While very effective at lowering pressure, these drains require lifelong monitoring for infection [14].
- Glaucoma Drainage Devices (GDD): A small tube (shunt) is placed in the eye to carry fluid to a reservoir tucked away under the eyelid [8][7].
The Importance of ‘Target IOP’
The Target IOP is not a universal number like “15” or “18.” It is an individualized goal set by the surgeon based on how much damage the optic nerve has already sustained [1].
- If the disease is advanced, the target might be very low (e.g., 10–12 mmHg).
- If the disease is caught early, the target might be slightly higher.
The “correct” pressure is the one that results in a stable visual field over time [15]. If the pressure remains above the target, it is usually a sign that it’s time to change the treatment plan [3].
Common questions in this guide
Why is surgery recommended over eye drops for JOAG?
What is the GATT procedure for glaucoma?
What is a 'Target IOP' in glaucoma treatment?
What happens if GATT or angle surgery doesn't work?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Why is surgery recommended now rather than continuing or adding more eye drops?
- 2.Are we a candidate for GATT, and do the genetic results make this procedure more likely to succeed?
- 3.What is the specific 'target IOP' we are trying to achieve, and what happens if we don't reach it with this surgery?
- 4.If GATT or goniotomy doesn't work, what is the 'backup' plan—a trabeculectomy or a drainage device (GDD)?
- 5.How will our long-term follow-up change after this surgery? How often will we need to check the pressure?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma.
Sihota R, Angmo D, Ramaswamy D, Dada T
Indian journal of ophthalmology 2018; (66(4)):495-505 doi:10.4103/ijo.IJO_1130_17.
PMID: 29582808 - 2
Evaluation of prolonged use of topical glaucoma medications on gonioscopy-assisted transluminal trabeculotomy outcomes in juvenile open-angle glaucoma.
Wang Z, Yang Z, Liu S, et al.
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2025; (14(6)):100240 doi:10.1016/j.apjo.2025.100240.
PMID: 40850605 - 3
Updates on the Diagnosis and Management of Glaucoma.
Wagner IV, Stewart MW, Dorairaj SK
Mayo Clinic proceedings. Innovations, quality & outcomes 2022; (6(6)):618-635 doi:10.1016/j.mayocpiqo.2022.09.007.
PMID: 36405987 - 4
A comparative study on surgical outcomes of trabeculectomy with and without anti-metabolites in juvenile open-angle glaucoma.
Senthilkumar VA, Rajendrababu S, Kavya K, et al.
Indian journal of ophthalmology 2023; (71(7)):2773-2778 doi:10.4103/IJO.IJO_457_23.
PMID: 37417119 - 5
Three-year outcomes of gonioscopy-assisted transluminal trabeculotomy for juvenile-onset primary open-angle glaucoma: a retrospective study.
Hu B, Liu S, Fan H, Zeng L
BMC ophthalmology 2025; (25(1)):170 doi:10.1186/s12886-025-03930-2.
PMID: 40181359 - 6
Outcome of Goniotomy Over 120, 240 and 360 Degrees in Juvenile Open Angle Glaucoma: A Multicenter Study.
Yang Z, Wang Z, Fan H, et al.
Journal of glaucoma 2025; (34(6)):433-439 doi:10.1097/IJG.0000000000002569.
PMID: 40105411 - 7
Outcomes of Second Trabeculectomy Versus Glaucoma Drainage Device in Juvenile Open Angle Glaucoma After Primary Trabeculectomy Failure.
Seresirikachorn K, Annopawong K, Parivisutt N, et al.
Journal of glaucoma 2025; (34(4)):297-303 doi:10.1097/IJG.0000000000002525.
PMID: 39661158 - 8
TUBE VERSUS TRABECULECTOMY IN JUVENILE-ONSET OPEN ANGLE GLAUCOMA - TREATMENT OUTCOMES IN TERTIARY HOSPITALS IN MALAYSIA.
Abd H, Ang , Raja N, et al.
Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 2022; (78(6)):298-303 doi:10.31348/2022/29.
PMID: 36543596 - 9
Gonioscopy-Assisted Transluminal Trabeculotomy for Myocilin-Associated Juvenile Open-Angle Glaucoma: A Case Series of 8 Eyes Over 2.2 to 4.1 Years.
Boese EA, Alward WLM, Fingert JH
Ophthalmology. Glaucoma 2025; (8(5)):466-473 doi:10.1016/j.ogla.2025.03.011.
PMID: 40188877 - 10
Gonioscopy-Assisted Transluminal Trabeculotomy for Myocilin Juvenile Glaucoma.
Boese EA, Alward WLM, Fingert JH
Ophthalmology. Glaucoma 2022; (5(3)):369-370 doi:10.1016/j.ogla.2021.07.003.
PMID: 34273563 - 11
Early outcomes of 5-0 prolene gonioscopy-assisted transluminal trabeculotomy in juvenile open-angle glaucoma.
Maheshwari D, Gupta S, Pillai MR, et al.
Indian journal of ophthalmology 2025; (73(Suppl 3)):S449-S453 doi:10.4103/IJO.IJO_1864_24.
PMID: 40444305 - 12
A Prospective Study of Intraocular Pressure Spike and Failure After Gonioscopy-Assisted Transluminal Trabeculotomy in Juvenile Open-Angle Glaucoma: A Prospective Study of GATT in JOAG.
Shi Y, Wang H, Oatts JT, et al.
American journal of ophthalmology 2022; (236()):79-88 doi:10.1016/j.ajo.2021.10.009.
PMID: 34695398 - 13
Treatment Outcomes for Juvenile Open Angle Glaucoma in Thailand.
Seresirikachorn K, Thiamthat W, Annopawong K, et al.
Journal of glaucoma 2023; (32(11)):976-982 doi:10.1097/IJG.0000000000002309.
PMID: 37725790 - 14
The art of fixing a ticking time bomb: Combined phacoemulsification and amniotic membrane transplantation.
Tang AC, Teh SS, Yong GY, et al.
Taiwan journal of ophthalmology 2024; (14(2)):275-278 doi:10.4103/tjo.TJO-D-23-00009.
PMID: 39027080 - 15
The Effect of Achieving Target Intraocular Pressure on Visual Field Worsening.
Villasana GA, Bradley C, Ramulu P, et al.
Ophthalmology 2022; (129(1)):35-44 doi:10.1016/j.ophtha.2021.08.025.
PMID: 34506846
This page provides educational information about JOAG surgical treatments. It is not a substitute for professional medical advice, diagnosis, or treatment from your ophthalmologist.
Get notified when new evidence is published on Juvenile glaucoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.